InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
4
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Mendelsohn Alan, Directeur Médical. Director active across 1 company, notably Timber Pharmaceuticals, Inc.. Aggregated, 5 filings have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €16k. History available since 3 March 2021. The latest transaction was filed on 20 August 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations5 total
35,193 shares0Common Stock, par value $0.001 per shareSEC:0001437749-23-024470:0
10,000 shares@ US$0.4727.0% of flowCommon Stock, par value $0.001 per shareSEC:0000905718-21-001534:0
Ideal exit: 20 Aug 2022 (T+270)
10,000 shares@ US$0.4753.9% of flowCommon Stock, par value $0.001 per shareSEC:0000905718-21-001534
Ideal exit: 20 Aug 2022 (T+270)
1,988 shares@ US$2.1723.0% of flowCommon Stock, par value $0.001 per shareSEC:0000905718-21-000665:0
Ideal exit: 28 Nov 2021 (T+270)
1,988 shares@ US$2.1723.0% of flowCommon Stock, par value $0.001 per shareSEC:0000905718-21-000665
Ideal exit: 28 Nov 2021 (T+270)
5 of 5 declarations
About Mendelsohn Alan
Alan Mendelsohn is the Chief Medical Officer at Timber Pharmaceuticals, Inc. He is responsible for overseeing the company's medical activities and clinical research. His medical expertise is essential in guiding product development initiatives and ensuring compliance with regulations.
